Replies to post #236354 on Biotech Values

[DewDiligence]

I doubt that the EpiPen business will see a material uptake on account of bad reactions to COVID vaccinations.

[DewDiligence]

HALO acquires ATRS for $5.60/sh cash—a 50% premium to yesterday’s close:

https://finance.yahoo.com/news/halozyme-acquire-antares-pharma-create-100000000.html

The nominal deal value is $960M.